Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10.

about

Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10.

Item

http://www.wikidata.org/entity/Q47119441

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Glypican-3 induces oncogenicit ...... that can be blocked by Grb10.

@en

Glypican-3 induces oncogenicit ...... that can be blocked by Grb10.

@nl

type

Item

label

Glypican-3 induces oncogenicit ...... that can be blocked by Grb10.

@en

Glypican-3 induces oncogenicit ...... that can be blocked by Grb10.

@nl

prefLabel

Glypican-3 induces oncogenicit ...... that can be blocked by Grb10.

@en

Glypican-3 induces oncogenicit ...... that can be blocked by Grb10.

@nl

P1476

Glypican-3 induces oncogenicit ...... that can be blocked by Grb10.

@en

P2093

Hey-Chi Hsu

http://www.w3.org/2001/XMLSchema#string

Hung-Wei Pan

http://www.w3.org/2001/XMLSchema#string

Po-Chun Huang

http://www.w3.org/2001/XMLSchema#string

Wei Cheng

http://www.w3.org/2001/XMLSchema#string

Yu-May Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor

Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma

Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma

Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma

Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases

Localization of endogenous Grb10 to the mitochondria and its interaction with the mitochondrial-associated Raf-1 pool

Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution

Grb10: A new substrate of the insulin-like growth factor I receptor

Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer

P304

80429-80442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19035

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wuh-liang Hwu

Yung-Ming Jeng

Hsiao-Mei Chao

P577

2017-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29113314

http://www.w3.org/2001/XMLSchema#string

P932

5655209

http://www.w3.org/2001/XMLSchema#string